Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Ceftriaxone-related fatal hemolysis in an adolescent with perinatally acquired human immunodeficiency virus infection. J Pediatr 1998 Aug;133(2):279-81

Date

08/26/1998

Pubmed ID

9709722

DOI

10.1016/s0022-3476(98)70236-7

Scopus ID

2-s2.0-0031928314   39 Citations

Abstract

A 14-year-old girl with perinatally acquired human immunodeficiency virus infection had fatal intravascular hemolysis after intravenous administration of ceftriaxone. Laboratory studies confirmed the presence of an antibody against ceftriaxone in the serum and on the patient's red blood cells. No evidence of sepsis, glucose-6-phosphate dehydrogenase deficiency or anaphylaxis was found.

Author List

Moallem HJ, Garratty G, Wakeham M, Dial S, Oligario A, Gondi A, Rao SP, Fikrig S

Author

Martin K. Wakeham MD Professor in the Pediatrics department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

AIDS-Related Opportunistic Infections
Adolescent
Anemia, Hemolytic
Antibodies
Ceftriaxone
Cephalosporins
Fatal Outcome
Female
HIV Infections
Hemolysis
Humans